M81	O
common	O
esr1	BG
gene	IG
alleles-4	IG
are	O
unlikely	O
to	O
contribute	O
to	O
obesity-10	BP
in	O
women	O
,	O
whereas	O
a	O
minor	O
importance	O
of	O
esr2-19	BG
on	O
severe	O
obesity-22	BP
cannot	O
be	O
excluded	O
.	O

M86	O
canine	O
atopic	BP
dermatitis-4	IP
is	O
a	O
genetically	O
-	O
predisposed	O
inflammatory	O
and	O
pruritic	O
allergic	O
skin	O
disease	O
,	O
most	O
commonly	O
associated	O
with	O
ige	BG
antibodies-22	IG
to	O
environmental	O
allergens	O
[	O
1	O
]	O
.	O

M121	O
a	O
plethora-2	BP
of	O
circumstantial	O
evidence	O
implicates	O
downregulation	O
of	O
the	O
cyclin	BG
-	IG
dependent	IG
kinase-13	IG
inhibitor	O
p27-15	BG
in	O
prostate	BP
cancer-18	IP
.	O

M129	O
while	O
our	O
study	O
suggests	O
that	O
skp2-6	BG
is	O
an	O
important	O
player	O
in	O
p27-12	BG
regulation	O
in	O
prostate	BP
cancer-16	IP
cells	O
,	O
recent	O
studies	O
have	O
also	O
implicated	O
another	O
protein	O
,	O
cop9-27	BG
/	O
signalosome5-29	BG
/	O
jab1-31	BG
,	O
in	O
p27-34	BG
regulation	O
.	O

M130	O
notably	O
,	O
like	O
skp2-4	BG
,	O
cop9	BG
/	IG
signalosome5-8	IG
was	O
found	O
to	O
be	O
overexpressed	O
in	O
cancers-15	BP
devoid	O
of	O
p27-18	BG
.	O

M131	O
we	O
propose	O
that	O
frequent	O
p27-5	BG
downregulation	O
in	O
prostate	BP
cancer-9	IP
may	O
be	O
caused	O
by	O
skp2-14	BG
overexpression	O
thus	O
enabling	O
escape	O
from	O
normal	O
androgen	O
control	O
.	O

M132	O
finally	O
,	O
our	O
in	O
vitro	O
studies	O
validate	O
the	O
skp2-9	BG
pathway	O
as	O
a	O
potential	O
target	O
for	O
therapeutic	O
intervention	O
in	O
cancers-19	BP
devoid	O
of	O
p27-22	BG
.	O

M184	O
that	O
the	O
other	O
members	O
of	O
the	O
dystrophin	BG
-	IG
glycoprotein-9	IG
complex	O
,	O
besides	O
dystrophin	O
,	O
play	O
a	O
role	O
in	O
the	O
duchenne	O
muscular	BP
dystrophy-22	IP
pathology	O
,	O
is	O
demonstrated	O
by	O
the	O
fact	O
that	O
primary	O
abnormalities	O
in	O
sarcoglycans	O
and	O
laminin-36	BG
are	O
responsible	O
for	O
certain	O
forms	O
of	O
limb	BP
-	IP
girdle	IP
muscular	IP
dystrophy-47	IP
and	O
congenital	BP
muscular	IP
dystrophy-51	IP
,	O
respectively	O
[	O
,	O
]	O
.	O

M193	O
nma-1	BG
,	O
encoding	O
a	O
putative	O
transmembrane	O
protein	O
,	O
is	O
expressed	O
at	O
low	O
levels	O
in	O
metastatic	O
human	O
melanoma-17	BP
cell	O
lines	O
and	O
xenografts	O
,	O
and	O
is	O
completely	O
absent	O
in	O
highly	O
metastatic	O
human	O
melanoma-31	BP
cell	O
lines	O
.	O

M241	O
human	O
pancreatic	BP
cancers-3	IP
overexpress	O
a	O
number	O
of	O
important	O
tyrosine	BG
kinase	IG
growth	IG
factor	IG
receptors-13	IG
and	O
their	O
ligands	O
,	O
such	O
as	O
those	O
belonging	O
to	O
the	O
epidermal	BG
growth	IG
factor-26	IG
,	O
fibroblast	BG
growth	IG
factor-30	IG
,	O
insulin	BG
-	IG
like	IG
growth	IG
factor-36	IG
(	O
igf	BG
-	IG
1-40	IG
)	O
,	O
and	O
vascular	BG
endothelial	IG
growth	IG
factor-47	IG
families	O
.	O

M250	O
the	O
sti571	BG
target	IG
c	IG
-	IG
kit-6	IG
and	O
its	O
ligand	O
stem	BG
cell	IG
factor-12	IG
have	O
been	O
shown	O
to	O
be	O
expressed	O
in	O
pancreatic	BP
cancer-21	IP
cells	O
.	O

M255	O
for	O
example	O
,	O
it	O
has	O
been	O
reported	O
that	O
the	O
mrna	O
levels	O
of	O
epidermal	BG
growth	IG
factor-15	IG
and	O
epidermal	BG
growth	IG
factorr-19	IG
are	O
markedly	O
increased	O
in	O
pancreatic	BP
cancer-25	IP
tissues	O
in	O
comparison	O
with	O
the	O
normal	O
pancreas	O
,	O
suggesting	O
that	O
the	O
coexpression	O
of	O
epidermal	BG
growth	IG
factorr-41	IG
and	O
its	O
ligands	O
may	O
contribute	O
to	O
the	O
aggressiveness-49	BP
of	O
human	O
pancreatic	BP
cancer-53	IP
.	O

M347	O
in	O
fact	O
,	O
the	O
finding	O
of	O
abnormal	BP
glucose	IP
homeostasis-9	IP
in	O
the	O
knockout	O
mice	O
for	O
fem1b	BG
gene-16	IG
,	O
the	O
identification	O
of	O
a	O
germline	O
missense	O
mutation	O
in	O
fem1a	BG
gene-27	IG
in	O
a	O
polycystic	BP
ovary-31	IP
syndrome	O
patient	O
and	O
the	O
observation	O
of	O
fem1a-38	BG
being	O
downregulated	O
in	O
human	O
rhabdomyosarcoma-43	BP
cell	O
lines	O
,	O
support	O
this	O
hypothesis	O
[	O
8	O
,	O
9	O
,	O
39	O
]	O
.	O

M409	O
the	O
most	O
salient	O
side	O
effects	O
of	O
acetylcholinesterase-7	BG
inhibitors	O
relate	O
to	O
increased	O
muscarinic	O
activity	O
and	O
include	O
nausea-16	BP
,	O
vomiting-18	BP
,	O
abdominal	O
cramping	O
,	O
diarrhea-23	BP
,	O
diaphoresis-25	BP
,	O
and	O
increased	BP
lacrimation-29	IP
,	O
salivation	O
,	O
and	O
bronchial	O
secretions	O
.	O

M440	O
it	O
has	O
been	O
observed	O
that	O
genetic	O
abnormalities	O
(	O
mutations	O
and	O
loss	O
of	O
heterozygosity	O
)	O
of	O
common	O
tumour	O
suppressor	O
genes	O
,	O
including	O
the	O
drosophila	BG
-	IG
homologous	IG
patched	IG
gene-50	IG
are	O
associated	O
with	O
the	O
basal	O
cell	O
naevus-57	BP
syndrome	O
(	O
as	O
well	O
as	O
some	O
other	O
epithelial	O
tumours	O
,	O
such	O
as	O
basal	BP
cell	IP
carcinomas-72	IP
)	O
.	O
